WAVEMAN · COMPANY

LIN · Linde Plc

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475

← ALL COMPANIES

LIN

Name: LINDE PLC (LIN) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

LINDE PLC

PHARMA & BIOTECH · INDUSTRIAL INORGANIC CHEMICALS · CIK 0001707925

CONGRESS · 2☆ WATCH

INSIDER NET · 180D

-$7.8M

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

1,217

13F, latest reported quarter

REVENUE GROWTH

+3.0%

XBRL, annual

NET MARGIN

20.3%

CONVERSIONS · 180D

codes C/M, not in net · $1.2M priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$7.8M over 180 days

+$47.9K over 90 days

below 82% of Pharma & Biotech

CONGRESS

2 members bought in the last year

more than 65% of Pharma & Biotech

FUNDS

1,217 funds added or opened last quarter

more than 99% of Pharma & Biotech

REVENUE

+3.0% year over year

more than 51% of Pharma & Biotech

MARGIN

20.3% net margin

more than 89% of Pharma & Biotech

BUYBACKS

$1.7B repurchased, FY to 2026-06-30

more than 97% of Pharma & Biotech

SHORT

1.2% of shares outstanding short · 2.6 days to cover · settled 2026-07-31

below 70% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

Insiders are net sellers: -$7.8M across 3 people in 180 days.

1,217 funds added or opened positions in the latest 13F quarter, of 2,344 holders.

2 members of Congress reported buying it this year.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +4.2%

+4.2%12M

INSIDER BUYINSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows a net $7.8M sold by insiders over 180 days, 1,217 funds added last quarter, 2 Congress member(s) bought in 12 months. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, LINDE PLC insiders sold a net $7.8M of stock across 66 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER

FILED

VALUE

Reynolds Paula Rosput

Director

BUY

2026-08-18

100.0

$47.9K

WOOD ROBERT L

Director

SELL

2026-05-15

4,335.0

$2.2M

WOOD ROBERT L

Director

SELL

2026-05-14

880.0

$447.7K

Durbin Sean

EVP, Chief Operating Officer

SELL

2026-03-10

4,114.0

$2.0M

Durbin Sean

EVP, Chief Operating Officer

SELL

2026-03-10

2,406.0

$1.1M

66 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 61 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

37,301,875.0 sh

$19.4B

VANGUARD CAPITAL MANAGEMENT LLC

30,208,556.0 sh

$15.7B

STATE STREET CORP

20,344,181.0 sh

$10.6B

Capital Research Global Investors

17,430,716.0 sh

$9.0B

Invesco Ltd.

15,321,341.0 sh

$8.0B

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

iShares U.S. Basic Materials ETF

$305.0M POSITION · AS OF 2026-04-30

19.9%

VANGUARD MATERIALS INDEX FUND

$687.8M POSITION · AS OF 2026-02-28

14.5%

PROFUND VP MATERIALS

$1.8M POSITION · AS OF 2026-03-31

14.2%

MATERIALS ULTRASECTOR PROFUND

$3.7M POSITION · AS OF 2026-04-30

10.4%

iShares Global Materials ETF

$24.9M POSITION · AS OF 2026-03-31

7.8%

Victory Global Energy Transition Fund

$30.3M POSITION · AS OF 2026-03-31

5.6%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Government contracts

USASpending.gov · total award ceilings over the contract's life, including awards won through subsidiaries — not annual revenue

National Aeronautics And Space Administration

DELIVERY ORDER FOR LIQUID NITROGEN FOR STENNIS SPACE CENTER (SSC) AS DESCRIBED ON KENNEDY SPACE CENT · 2024-07-11

$17.9M

National Aeronautics And Space Administration

SSC DELIVERY ORDER (DO) FOR GASEOUS HELIUM (GHE) · 2025-10-01

$6.1M

FEDERAL AWARDS ≥ $25M IN THE LAST 90 DAYS · MATCHED VIA SAM.GOV PARENT REGISTRY

Executive pay vs shareholder return

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2025

$21.8M

$15.9M

$6.3M

+73%

+39%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$34.0B	$33.0B	$32.9B	$33.4B
OPERATING INCOME	$8.9B	$8.6B	$8.0B	$5.4B
NET INCOME	$6.9B	$6.6B	$6.2B	$4.1B
EPS (DILUTED)	14.61	13.62	12.59	8.23
OPERATING CASH FLOW	$10.3B	$9.4B	$9.3B	$8.9B
CASH	$5.1B	$4.8B	$4.7B	$5.4B
LONG-TERM DEBT	$20.7B	$15.3B	$13.4B	$12.2B
BUYBACKS	$4.6B	$4.5B	$4.0B	$5.2B
DIVIDENDS PAID	$2.8B	$2.7B	$2.5B	$2.3B

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE